logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2018 – French study exposes barriers to the inclusion of 12 to 25-year-olds in both adult and paediatric phase 1 and 2 clinical trials

A more flexible and tailored approach to trial recruitment could help 12 to 25-year-old patients by giving them access to new cancer treatments.